Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Elaine J. Tanhehco MD

Elaine J. Tanhehco MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Radiology

View Curriculum Vitae

Publications (28)

  • Precise Image-level Localization of Intracranial Hemorrhage on Head CT Scans with Deep Learning Models Trained on Study-level Labels. (Wu Y, Iorga M, Badhe S, Zhang J, Cantrell DR, Tanhehco EJ, Szrama N, Naidech AM, Drakopoulos M, Hasan ST, Patel KM, Hijaz TA, Russell EJ, Lalvani S, Adate A, Parrish TB, Katsaggelos AK, Hill VB) Radiol Artif Intell 2024 Nov;6(6):e230296 PMID: 39194400 PMCID: PMC11605431 SCOPUS ID: 2-s2.0-85211328173 08/28/2024       3 Citations
  • Actin dynamics is rapidly regulated by the PTEN and PIP2 signaling pathways leading to myocyte hypertrophy. (Li J, Tanhehco EJ, Russell B) Am J Physiol Heart Circ Physiol 2014 Dec 01;307(11):H1618-25 PMID: 25260617 PMCID: PMC4255012 SCOPUS ID: 2-s2.0-84913555319 09/28/2014       28 Citations
  • Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure. (Suzuki G, Khanal S, Rastogi S, Morita H, Mishima T, Anagnostopoulos PV, Nass O, Sharov VG, Tanhehco EJ, Goldstein S, Sabbah HN) Cardiovasc Drugs Ther 2007 Feb;21(1):29-36 PMID: 17294127 SCOPUS ID: 2-s2.0-34247137270 02/13/2007       7 Citations
  • Long-term therapy with the acorn cardiac support device normalizes gene expression of growth factors and gelatinases in dogs with heart failure. (Rastogi S, Gupta RC, Mishra S, Morita H, Tanhehco EJ, Sabbah HN) J Heart Lung Transplant 2005 Oct;24(10):1619-25 PMID: 16210139 SCOPUS ID: 2-s2.0-25844454886 10/08/2005       21 Citations
  • Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs. (Morita H, Suzuki G, Haddad W, Mika Y, Tanhehco EJ, Goldstein S, Ben-Haim S, Sabbah HN) Eur J Heart Fail 2004 Mar 01;6(2):145-50 PMID: 14984721 SCOPUS ID: 2-s2.0-1342345253 02/27/2004       29 Citations
  • Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment. (Sabbah HN, Sharov VG, Gupta RC, Mishra S, Rastogi S, Undrovinas AI, Chaudhry PA, Todor A, Mishima T, Tanhehco EJ, Suzuki G) Circ Res 2003 Nov 28;93(11):1095-101 PMID: 14563716 SCOPUS ID: 2-s2.0-0344874743 10/18/2003       98 Citations
  • Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. (Morita H, Suzuki G, Mishima T, Chaudhry PA, Anagnostopoulos PV, Tanhehco EJ, Sharov VG, Goldstein S, Sabbah HN) Cardiovasc Drugs Ther 2002 Sep;16(5):443-9 PMID: 12652114 SCOPUS ID: 2-s2.0-0037001786 03/26/2003       34 Citations
  • Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1. (Sharov VG, Todor A, Suzuki G, Morita H, Tanhehco EJ, Sabbah HN) Eur J Heart Fail 2003 Mar;5(2):121-9 PMID: 12644001 SCOPUS ID: 2-s2.0-0037352731 03/20/2003       43 Citations
  • Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. (Morita H, Suzuki G, Haddad W, Mika Y, Tanhehco EJ, Sharov VG, Goldstein S, Ben-Haim S, Sabbah HN) J Card Fail 2003 Feb;9(1):69-75 PMID: 12612875 SCOPUS ID: 2-s2.0-0037299675 03/04/2003       59 Citations
  • Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure. (Suzuki G, Mishima T, Tanhehco EJ, Sharov VG, Todor A, Rostogi S, Gupta RC, Chaudhry PA, Anagnostopoulos PV, Nass O, Goldstein S, Sabbah HN) Br J Pharmacol 2003 Jan;138(2):301-9 PMID: 12540520 PMCID: PMC1573662 SCOPUS ID: 2-s2.0-0037277959 01/24/2003       9 Citations
  • Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. (Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, Tanhehco EJ, Rudolph AE, McMahon EG, Goldstein S, Sabbah HN) Circulation 2002 Dec 03;106(23):2967-72 PMID: 12460880 SCOPUS ID: 2-s2.0-0037016007 12/04/2002       205 Citations
  • Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure. (Mishima T, Tanimura M, Suzuki G, Todor A, Sharov VG, Tanhehco EJ, Goldstein S, Sabbah HN) Cardiovasc Drugs Ther 2002 May;16(3):209-14 PMID: 12374898 SCOPUS ID: 2-s2.0-0036437729 10/11/2002       9 Citations
  • Hypoxia-induced cleavage of caspase-3 and DFF45/ICAD in human failed cardiomyocytes. (Todor A, Sharov VG, Tanhehco EJ, Silverman N, Bernabei A, Sabbah HN) Am J Physiol Heart Circ Physiol 2002 Sep;283(3):H990-5 PMID: 12181128 SCOPUS ID: 2-s2.0-0036352616 08/16/2002       27 Citations
  • Therapeutic potential of complement inhibitors in myocardial ischaemia. (Lucchesi BR, Tanhehco EJ) Expert Opin Investig Drugs 2000 May;9(5):975-91 PMID: 11060721 SCOPUS ID: 2-s2.0-0034060551 11/04/2000       17 Citations
  • Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection. (Tanhehco EJ, Lee H, Lucchesi BR) Immunopharmacology 2000 Sep;49(3):391-9 PMID: 10996036 SCOPUS ID: 2-s2.0-0033833623 09/21/2000       11 Citations
  • Preconditioning reduces myocardial complement gene expression in vivo. (Tanhehco EJ, Yasojima K, McGeer PL, McGeer EG, Lucchesi BR) Am J Physiol Heart Circ Physiol 2000 Sep;279(3):H1157-65 PMID: 10993779 SCOPUS ID: 2-s2.0-0033834774 09/20/2000       24 Citations
  • Free radicals upregulate complement expression in rabbit isolated heart. (Tanhehco EJ, Yasojima K, McGeer PL, Washington RA, Lucchesi BR) Am J Physiol Heart Circ Physiol 2000 Jul;279(1):H195-201 PMID: 10899056 SCOPUS ID: 2-s2.0-0033861321 07/19/2000       28 Citations
  • Acute cocaine exposure up-regulates complement expression in rabbit heart. (Tanhehco EJ, Yasojima K, McGeer PL, Lucchesi BR) J Pharmacol Exp Ther 2000 Jan;292(1):201-8 PMID: 10604949 SCOPUS ID: 2-s2.0-0033966847 12/22/1999       7 Citations
  • Preconditioning reduces tissue complement gene expression in the rabbit isolated heart. (Tanhehco EJ, Yasojima K, McGeer PL, Washington RA, Kilgore KS, Homeister JW, Lucchesi BR) Am J Physiol 1999 Dec;277(6):H2373-80 PMID: 10600858 SCOPUS ID: 2-s2.0-0033379024 12/22/1999       22 Citations
  • The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system. (Tanhehco EJ, Kilgore KS, Liff DA, Murphy KL, Fung MS, Sun WN, Sun C, Lucchesi BR) Transplant Proc 1999 Aug;31(5):2168-71 PMID: 10456004 SCOPUS ID: 2-s2.0-0032789867 08/24/1999       18 Citations
  • Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion. (Kilgore KS, Tanhehco EJ, Naylor KB, Lucchesi BR) J Pharmacol Exp Ther 1999 Sep;290(3):1041-7 PMID: 10454476 SCOPUS ID: 2-s2.0-0032813027 08/24/1999       19 Citations
  • Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfate. (Tanhehco EJ, Kilgore KS, Naylor KB, Park JL, Booth EA, Lucchesi BR) J Cardiovasc Pharmacol 1999 Jul;34(1):153-61 PMID: 10413082 SCOPUS ID: 2-s2.0-0032986154 07/21/1999       33 Citations
  • The semisynthetic polysaccharide pentosan polysulfate prevents complement-mediated myocardial injury in the rabbit perfused heart. (Kilgore KS, Naylor KB, Tanhehco EJ, Park JL, Booth EA, Washington RA, Lucchesi BR) J Pharmacol Exp Ther 1998 Jun;285(3):987-94 PMID: 9618399 SCOPUS ID: 2-s2.0-0031808657 06/17/1998       35 Citations
  • Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion. (Kilgore KS, Park JL, Tanhehco EJ, Booth EA, Marks RM, Lucchesi BR) J Mol Cell Cardiol 1998 Jan;30(1):75-85 PMID: 9500866 SCOPUS ID: 2-s2.0-0031890261 03/17/1998       50 Citations
  • Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics. (Kilgore KS, Tanhehco EJ, Park JL, Naylor KB, Anderson MB, Lucchesi BR) J Pharmacol Exp Ther 1998 Jan;284(1):427-35 PMID: 9435207 SCOPUS ID: 2-s2.0-0031887628 01/22/1998       21 Citations
  • Reviparin-sodium prevents complement-mediated myocardial injury in the isolated rabbit heart. (Park JL, Tanhehco EJ, Kilgore KS, Gralinski MR, Lucchesi BR) J Cardiovasc Pharmacol 1997 Nov;30(5):658-66 PMID: 9388049 SCOPUS ID: 2-s2.0-0030784613 12/05/1997       5 Citations
  • Protective Effects of Ranolazine on Ventricular Fibrillation Induced by Activation of the ATP-Dependent Potassium Channel in the Rabbit Heart. (Gralinski MR, Chi L, Park JL, Friedrichs GS, Tanhehco EJ, McCormack JG, Lucchesi BR) J Cardiovasc Pharmacol Ther 1996 Apr;1(2):141-148 PMID: 10684411 SCOPUS ID: 2-s2.0-0001440335 04/01/1996       28 Citations
  • Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart. (Chi L, Park JL, Friedrichs GS, Banglawala YA, Perez MA, Tanhehco EJ, Lucchesi BR) Br J Pharmacol 1996 Mar;117(6):1261-9 PMID: 8882624 PMCID: PMC1909761 SCOPUS ID: 2-s2.0-0029919612 03/01/1996       26 Citations
    • Last update: 10/23/2025